← Back to patent-cliff list
CAS 67590-29-8
2-tert-Butyl-2-(hydroxymethyl)propane-1,3-diol
Codes：(IIb)409139-5-a
Application context (from source-drug indications)
转甲状腺素运载蛋白淀粉样变性氯苯唑酸心脏病氯苯唑酸
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 氯苯唑酸Tafamidis | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3-Methylbutanal→3,3-Dimethylbutanal→2-(Hydroxymethyl)-2-(propan-2-yl)propane-1,3-diol→2-tert-Butyl-2-(hydroxymethyl)propane-1,3-diol→3,5-Dichlorobenzoic acid→1-(3,5-Dichlorophenyl)-4-(propan-2-yl)-2,6,7-trioxabicyclo[2.2.2]octane→4-tert-Butyl-1-(3,5-dichlorophenyl)-2,6,7-trioxabicyclo[2.2.2]octane→(4-Carboxy-2-hydroxyphenyl)amine→2-(3,5-Dichlorophenyl)benzo[d]oxazole-6-carboxylic acid
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.